Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥446.51 Million ≈ $65.34 Million USD) by net assets (CN¥10.70 Billion ≈ $1.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shijiazhuang Yiling Pharmaceutical Co Lt defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Shijiazhuang Yiling Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Shijiazhuang Yiling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shijiazhuang Yiling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Airoha Technology Corp
TW:6526
0.071x
Otter Tail Corporation
NASDAQ:OTTR
0.037x
Beijing Shougang Co Ltd
SHE:000959
0.059x
Cal-Maine Foods Inc
NASDAQ:CALM
0.038x
OSI Systems Inc
NASDAQ:OSIS
0.074x
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
0.027x
Sime Darby Bhd
KLSE:4197
0.065x
Huaxin Cement Co Ltd A
SHG:600801
0.092x

Annual Cash Flow Conversion Efficiency for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Shijiazhuang Yiling Pharmaceutical Co Lt (002603) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥10.98 Billion
≈ $1.61 Billion
CN¥1.78 Billion
≈ $259.96 Million
0.162x +170.10%
2024-12-31 CN¥10.20 Billion
≈ $1.49 Billion
CN¥611.01 Million
≈ $89.41 Million
0.060x +340.66%
2023-12-31 CN¥11.44 Billion
≈ $1.67 Billion
CN¥155.46 Million
≈ $22.75 Million
0.014x -95.74%
2022-12-31 CN¥10.93 Billion
≈ $1.60 Billion
CN¥3.49 Billion
≈ $510.37 Million
0.319x +447.55%
2021-12-31 CN¥9.07 Billion
≈ $1.33 Billion
CN¥528.69 Million
≈ $77.36 Million
0.058x -67.22%
2020-12-31 CN¥8.92 Billion
≈ $1.31 Billion
CN¥1.59 Billion
≈ $232.11 Million
0.178x +1950.92%
2019-12-31 CN¥7.95 Billion
≈ $1.16 Billion
CN¥68.93 Million
≈ $10.09 Million
0.009x -9.41%
2018-12-31 CN¥7.56 Billion
≈ $1.11 Billion
CN¥72.37 Million
≈ $10.59 Million
0.010x -40.65%
2017-12-31 CN¥7.11 Billion
≈ $1.04 Billion
CN¥114.65 Million
≈ $16.78 Million
0.016x -86.60%
2016-12-31 CN¥5.33 Billion
≈ $780.36 Million
CN¥641.45 Million
≈ $93.86 Million
0.120x +340.29%
2015-12-31 CN¥4.83 Billion
≈ $706.40 Million
CN¥131.88 Million
≈ $19.30 Million
0.027x +13.93%
2014-12-31 CN¥4.42 Billion
≈ $646.31 Million
CN¥105.90 Million
≈ $15.50 Million
0.024x +84.57%
2013-12-31 CN¥4.26 Billion
≈ $623.13 Million
CN¥55.32 Million
≈ $8.10 Million
0.013x -28.77%
2012-12-31 CN¥3.84 Billion
≈ $562.64 Million
CN¥70.13 Million
≈ $10.26 Million
0.018x +116.53%
2011-12-31 CN¥3.70 Billion
≈ $541.67 Million
CN¥-408.49 Million
≈ $-59.77 Million
-0.110x -140.17%
2010-12-31 CN¥1.09 Billion
≈ $159.65 Million
CN¥299.72 Million
≈ $43.86 Million
0.275x -31.75%
2009-12-31 CN¥790.55 Million
≈ $115.68 Million
CN¥318.21 Million
≈ $46.56 Million
0.403x -7.30%
2008-12-31 CN¥484.03 Million
≈ $70.83 Million
CN¥210.18 Million
≈ $30.76 Million
0.434x --

About Shijiazhuang Yiling Pharmaceutical Co Ltd

SHE:002603 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.67 Billion
CN¥25.09 Billion CNY
Market Cap Rank
#4411 Global
#746 in China
Share Price
CN¥15.02
Change (1 day)
+0.47%
52-Week Range
CN¥13.91 - CN¥21.05
All Time High
CN¥1254.44
About

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine in China and internationally. It offers dietary supplements, and healthy food and drinks; patent TCM products for respiratory health, cardiovascular disease, diabetes, mellitus, oncology, urologic disease, sleep-improving, and anti-aging; disinfection and pers… Read more